These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11365287)

  • 21. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada.
    Johnson S; MacDonald SF; Cheverie M; Myrick C; Fischer B
    Drug Alcohol Depend; 2012 Jul; 124(1-2):172-6. PubMed ID: 22265193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct; 12(20):7. PubMed ID: 11364789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV/AIDS behind bars.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1998 Apr; 4(4):8-13. PubMed ID: 11365184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid substitution therapy for people living in German prisons-inequality compared with civic sector.
    Stöver H; Jamin D; Michels II; Knorr B; Keppler K; Deimel D
    Harm Reduct J; 2019 Dec; 16(1):72. PubMed ID: 31864356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attitudes and practices regarding the use of methadone in US state and federal prisons.
    Rich JD; Boutwell AE; Shield DC; Key RG; McKenzie M; Clarke JG; Friedmann PD
    J Urban Health; 2005 Sep; 82(3):411-9. PubMed ID: 15917502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan.
    Azbel L; Rozanova J; Michels I; Altice FL; Stöver H
    Harm Reduct J; 2017 Jul; 14(1):43. PubMed ID: 28693573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The politics of harm reduction in federal prisons.
    Watson TM
    Int J Drug Policy; 2014 Sep; 25(5):916-23. PubMed ID: 25018152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions to reduce HIV transmission related to injecting drug use in prison.
    Jürgens R; Ball A; Verster A
    Lancet Infect Dis; 2009 Jan; 9(1):57-66. PubMed ID: 19095196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of outcome in methadone programs: effect of HIV counseling and testing.
    Farley TA; Cartter ML; Wassell JT; Hadler JL
    Conn Med; 1994 Mar; 58(3):165-71. PubMed ID: 8039381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring harm reduction in European prisons via the Dublin Declaration.
    Lines R; Stöver H; Donochoe MC; Lazarus JV
    Int J Prison Health; 2009; 5(4):251-5. PubMed ID: 25757526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.
    Drucker E; Lurie P; Wodak A; Alcabes P
    AIDS; 1998; 12 Suppl A():S217-30. PubMed ID: 9633006
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV/AIDS in prisons: more new developments.
    Jürgens R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):64-8, 71-5. PubMed ID: 11833204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. U.S. prisons fail to adopt proven prevention measures, experts say.
    AIDS Policy Law; 1997 Apr; 12(6):1, 9-10. PubMed ID: 11364177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linkage with methadone treatment upon release from incarceration: a promising opportunity.
    Rich JD; McKenzie M; Shield DC; Wolf FA; Key RG; Poshkus M; Clarke J
    J Addict Dis; 2005; 24(3):49-59. PubMed ID: 16186082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methadone. Reducing the transmission of HIV].
    Sabourin G
    Perspect Infirm; 2013; 10(3):56. PubMed ID: 23705283
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of substitution treatment in prisons--a literature review.
    Stallwitz A; Stöver H
    Int J Drug Policy; 2007 Dec; 18(6):464-74. PubMed ID: 18061872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone maintenance treatment in prisons: The New South Wales Experience.
    Hall W; Ward J; Mattick R
    Drug Alcohol Rev; 1993; 12(2):193-203. PubMed ID: 16818329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Needle exchange programs in prisons in Spain.
    Menoyo C; Zulaica D; Parras F
    Can HIV AIDS Policy Law Rev; 2000; 5(4):20-1. PubMed ID: 11833158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prison optics.
    CMAJ; 2002 Nov; 167(10):1093, 1095. PubMed ID: 12427686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.